These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 11051374

  • 1. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer.
    Bleeker WA, Hayes VM, Karrenbeld A, Hofstra RM, Hermans J, Buys CC, Plukker JT.
    Am J Gastroenterol; 2000 Oct; 95(10):2953-7. PubMed ID: 11051374
    [Abstract] [Full Text] [Related]

  • 2. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.
    Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N, TP53-CRC Collaborative Study Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7518-28. PubMed ID: 16172461
    [Abstract] [Full Text] [Related]

  • 3. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
    de Jong KP, Gouw AS, Peeters PM, Bulthuis M, Menkema L, Porte RJ, Slooff MJ, van Goor H, van den Berg A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4067-73. PubMed ID: 15930341
    [Abstract] [Full Text] [Related]

  • 4. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
    Westra JL, Schaapveld M, Hollema H, de Boer JP, Kraak MM, de Jong D, ter Elst A, Mulder NH, Buys CH, Hofstra RM, Plukker JT.
    J Clin Oncol; 2005 Aug 20; 23(24):5635-43. PubMed ID: 16110022
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer.
    Bleeker WA, Hayes VM, Karrenbeld A, Hofstra RM, Verlind E, Hermans J, Poppema S, Buys CH, Plukker JT.
    Dis Colon Rectum; 2001 Mar 20; 44(3):358-63. PubMed ID: 11289281
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival.
    Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H, Colon/Rectum Carcinomas (Primary Tumor) Study Group.
    Dis Colon Rectum; 2010 Jan 20; 53(1):57-64. PubMed ID: 20010352
    [Abstract] [Full Text] [Related]

  • 7. The impact of tumor location on the histopathologic expression of colorectal cancer.
    Papagiorgis P, Oikonomakis I, Karapanagiotou I, Wexner SD, Nikiteas N.
    J BUON; 2006 Jan 20; 11(3):317-21. PubMed ID: 17309156
    [Abstract] [Full Text] [Related]

  • 8. Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors.
    Sjo OH, Berg M, Merok MA, Kolberg M, Svindland A, Lothe RA, Nesbakken A.
    J Surg Oncol; 2011 Dec 20; 104(7):792-7. PubMed ID: 21547915
    [Abstract] [Full Text] [Related]

  • 9. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology.
    Nawa T, Kato J, Kawamoto H, Okada H, Yamamoto H, Kohno H, Endo H, Shiratori Y.
    J Gastroenterol Hepatol; 2008 Mar 20; 23(3):418-23. PubMed ID: 17532785
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon.
    Pricolo VE, Finkelstein SD, Wu TT, Keller G, Bakker A, Swalsky PA, Bland KI.
    Am J Surg; 1996 Jan 20; 171(1):41-6. PubMed ID: 8554149
    [Abstract] [Full Text] [Related]

  • 11. p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site.
    Lenz HJ, Danenberg KD, Leichman CG, Florentine B, Johnston PG, Groshen S, Zhou L, Xiong YP, Danenberg PV, Leichman LP.
    Clin Cancer Res; 1998 May 20; 4(5):1227-34. PubMed ID: 9607581
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of specific KRAS mutations in lung adenocarcinomas.
    Siegfried JM, Gillespie AT, Mera R, Casey TJ, Keohavong P, Testa JR, Hunt JD.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct 20; 6(10):841-7. PubMed ID: 9332768
    [Abstract] [Full Text] [Related]

  • 13. Implication of the BRCA2 and putative "BRCA3" genes in Dukes' stage C, replication error-negative colon cancer.
    Sivarajasingham NS, Cawkwell L, Baker RP, O'Kane SL, Smyth EF, Tilsed JV, Watson MB, Greenman J, Monson JR.
    Ann Surg Oncol; 2006 Jun 20; 13(6):881-6. PubMed ID: 16614877
    [Abstract] [Full Text] [Related]

  • 14. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ.
    Clin Cancer Res; 2002 May 20; 8(5):1117-24. PubMed ID: 12006527
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of oncogenesis in colon versus rectal cancer.
    Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RA, Moriya Y, van de Velde CJ, van Krieken JH.
    J Pathol; 2001 Sep 20; 195(2):171-8. PubMed ID: 11592095
    [Abstract] [Full Text] [Related]

  • 16. K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers.
    Lee JC, Wang ST, Lai MD, Lin YJ, Yang HB.
    Anticancer Res; 1996 Sep 20; 16(6B):3839-44. PubMed ID: 9042267
    [Abstract] [Full Text] [Related]

  • 17. Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection.
    Molleví DG, Serrano T, Ginestà MM, Valls J, Torras J, Navarro M, Ramos E, Germà JR, Jaurrieta E, Moreno V, Figueras J, Capellà G, Villanueva A.
    Carcinogenesis; 2007 Jun 20; 28(6):1241-6. PubMed ID: 17259658
    [Abstract] [Full Text] [Related]

  • 18. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V, Migliavacca M, Zanna I, Tubiolo C, Corsale S, Calò V, Amato A, Cammareri P, Latteri F, Grassi N, Fulfaro F, Porcasi R, Morello V, Nuara RB, Dardanoni G, Salerno S, Valerio MR, Dusonchet L, Gerbino A, Gebbia N, Tomasino RM, Russo A.
    J Cancer Res Clin Oncol; 2002 Dec 20; 128(12):650-8. PubMed ID: 12474051
    [Abstract] [Full Text] [Related]

  • 19. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
    Soong R, Grieu F, Robbins P, Dix B, Chen D, Parsons R, House A, Iacopetta B.
    Clin Cancer Res; 1997 Aug 20; 3(8):1405-11. PubMed ID: 9815825
    [Abstract] [Full Text] [Related]

  • 20. TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival.
    Børresen-Dale AL, Lothe RA, Meling GI, Hainaut P, Rognum TO, Skovlund E.
    Clin Cancer Res; 1998 Jan 20; 4(1):203-10. PubMed ID: 9516972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.